PMID: 30020741Jul 19, 2018Paper

Cost per response analysis of strategies for chronic immune thrombocytopenia

The American Journal of Managed Care
Kelly FustDavid Chandler

Abstract

This analysis estimated the cost per response and the incremental cost per additional responder of romplostim, eltrombopag, and the "watch-and-rescue" (monitoring until rescue therapies are required) strategy in adults with chronic immune thrombocytopenia (ITP). The decision tree is designed to estimate the total cost per response for romiplostim, eltrombopag, and watch and rescue over a 24-week time horizon; cost-effectiveness was evaluated in terms of incremental cost per additional responder. Model inputs including response rates, bleeding-related episode (BRE) rates, and costs were estimated from registrational trial data, an independent Bayesian indirect comparison, database analyses, and peer-reviewed publications. Costs were applied to the proportions of patients with treatment response and nonresponse (based on platelet count). The total cost per response and the incremental cost per additional responder for each treatment were calculated. Sensitivity analyses and alternative analyses were performed. With higher total costs and greater treatment efficacy, romiplostim and eltrombopag had a lower 24-week cost per response and a lower average number of BREs than watch and rescue. Eltrombopag was weakly dominated by romiplo...Continue Reading

Related Concepts

Related Feeds

Benign Rolandic Epilepsy

Benign Rolandic epilepsy is a partial idiopathic epilepsy of childhood presenting with a nocturnal seizure and with a typical EEG showing centrotemporal spike and multifocal or generalized sharp slow waves. Here is the latest research.

Related Papers

Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research
Rachel AllenBethan Woods
International Journal of Technology Assessment in Health Care
Katy L CooperRon Akehurst
British Journal of Haematology
José Ramón González-PorrasTomás José González-López
© 2022 Meta ULC. All rights reserved